The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial

The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial

Abstract Background Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders characterized by recurrent abdominal pain associated with defecation or a change in bowel habits. Leading to significant negative effect on patients’ quality of life and huge financial...

Full description

Bibliographic Details
Main Authors: Tao Bai, Haoyu Zeng, Yanqin Long, Xiaoqing Li, Xiaohong Sun, Yu Lan, Lingling Gao, Lu Zhang, Zenghui Feng, Xiaohua Hou
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Irritable bowel syndrome
Diarrhea predominant IBS
Randomized controlled trial
Efficacy
Probiotics
Online Access:http://link.springer.com/article/10.1186/s13063-020-04490-0

Internet

http://link.springer.com/article/10.1186/s13063-020-04490-0

Similar Items